BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28285357)

  • 1. Alternative outcomes of pathogenic complex somatic structural variations in the genomes of NF1 and NF2 patients.
    Hsiao MC; Piotrowski A; Poplawski AB; Callens T; Fu C; Messiaen L
    Neurogenetics; 2017 Jul; 18(3):169-174. PubMed ID: 28285357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 single and multi-exons copy number variations in neurofibromatosis type 1.
    Imbard A; Pasmant E; Sabbagh A; Luscan A; Soares M; Goussard P; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanne-Chantelot C; Vidaud D; Wolkenstein P; ; Parfait B
    J Hum Genet; 2015 Apr; 60(4):221-4. PubMed ID: 25631097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.
    De Luca A; Bottillo I; Dasdia MC; Morella A; Lanari V; Bernardini L; Divona L; Giustini S; Sinibaldi L; Novelli A; Torrente I; Schirinzi A; Dallapiccola B
    J Med Genet; 2007 Dec; 44(12):800-8. PubMed ID: 18055911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.
    Wimmer K; Yao S; Claes K; Kehrer-Sawatzki H; Tinschert S; De Raedt T; Legius E; Callens T; Beiglböck H; Maertens O; Messiaen L
    Genes Chromosomes Cancer; 2006 Mar; 45(3):265-76. PubMed ID: 16283621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
    Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
    J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding NF1 Intragenic Copy-Number Variations.
    Hsiao MC; Piotrowski A; Callens T; Fu C; Wimmer K; Claes KB; Messiaen L
    Am J Hum Genet; 2015 Aug; 97(2):238-49. PubMed ID: 26189818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exonic deletions in the NF1 gene in patients with neurofibromatosis type I from the lower Silesian region of Poland.
    Laczmańska I; Szczepaniak M; Jakubiak A; Stembalska A
    Adv Clin Exp Med; 2014; 23(4):517-21. PubMed ID: 25166435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of neurofibromatosis in southern Brazil.
    Rosset C; Vairo F; Cristina Bandeira I; Fonini M; Netto CBO; Ashton-Prolla P
    Expert Rev Mol Diagn; 2018 Jun; 18(6):577-586. PubMed ID: 29685074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Detection of
    Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).
    Messiaen L; Vogt J; Bengesser K; Fu C; Mikhail F; Serra E; Garcia-Linares C; Cooper DN; Lazaro C; Kehrer-Sawatzki H
    Hum Mutat; 2011 Feb; 32(2):213-9. PubMed ID: 21280148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1.
    Alesi V; Lepri FR; Dentici ML; Genovese S; Sallicandro E; Bejo K; Dallapiccola B; Capolino R; Novelli A; Digilio MC
    Eur J Hum Genet; 2022 Nov; 30(11):1239-1243. PubMed ID: 35879407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly sensitive genetic protocol to detect NF1 mutations.
    Valero MC; Martín Y; Hernández-Imaz E; Marina Hernández A; Meleán G; Valero AM; Javier Rodríguez-Álvarez F; Tellería D; Hernández-Chico C
    J Mol Diagn; 2011 Mar; 13(2):113-22. PubMed ID: 21354044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex Ligation-dependent Probe Amplification (MLPA®) for the detection of copy number variation in genomic sequences.
    Eijk-Van Os PG; Schouten JP
    Methods Mol Biol; 2011; 688():97-126. PubMed ID: 20938835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.
    Abo-Dalo B; Kutsche K; Mautner V; Kluwe L
    Genes Chromosomes Cancer; 2010 Feb; 49(2):171-5. PubMed ID: 19924781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy.
    Pasmant E; Louvrier C; Luscan A; Cohen J; Laurendeau I; Vidaud M; Vidaud D; Goutagny S; Kalamarides M; Parfait B
    Neurochirurgie; 2018 Nov; 64(5):335-341. PubMed ID: 26073919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions.
    Steinmann K; Kluwe L; Cooper DN; Brems H; De Raedt T; Legius E; Mautner VF; Kehrer-Sawatzki H
    Eur J Hum Genet; 2008 May; 16(5):572-80. PubMed ID: 18212816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele.
    Orzan F; Stroppi M; Venturin M; Valero MC; Hernández C; Riva P
    Neurogenetics; 2008 May; 9(2):95-100. PubMed ID: 18196300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
    Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
    Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements.
    De Lellis L; Curia MC; Catalano T; De Toffol S; Bassi C; Mareni C; Bertario L; Battista P; Mariani-Costantini R; Radice P; Cama A
    Hum Mutat; 2006 Oct; 27(10):1047-56. PubMed ID: 16941473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.